Author: digi

Phase 4 Trials in Nutraceuticals and Over-the-Counter (OTC) Products

June 20, 2025

Phase 4 Trials in Nutraceuticals and Over-the-Counter (OTC) Products Conducting Phase 4 Clinical Trials for Nutraceuticals and OTC Products: A Post-Marketing Framework Introduction Unlike prescription pharmaceuticals, nutraceuticals and over-the-counter (OTC) products are widely used by consumers without routine physician supervision. Yet their safety, effectiveness, and real-world impact often lack rigorous post-marketing evaluation. Phase 4 clinical…

Phase 4 (Post-Marketing Surveillance)

When to Choose Home Health Over Site Visits in Decentralized Clinical Trials

June 20, 2025

digi

When to Choose Home Health Over Site Visits in Decentralized Clinical Trials Determining When Home Health Visits Are Better Than Site Visits in Clinical Trials In the evolving landscape of decentralized clinical trials (DCTs), sponsors and investigators increasingly leverage home health visits as a substitute or complement to traditional site visits. These in-home interactions allow…

Decentralized Clinical Trials (DCTs), Home Health Visits

Patient and Investigator Bias in Unblinded Designs – Clinical Trial Design and Protocol Development

June 20, 2025

digi

Patient and Investigator Bias in Unblinded Designs – Clinical Trial Design and Protocol Development “Subject and Researcher Prejudice in Non-Double-Blind Studies” Introduction In clinical studies, maintaining the integrity and accuracy of data is of paramount importance. One of the significant challenges to this integrity is the potential for bias, particularly in unblinded study designs. Bias…

Clinical Trial Design and Protocol Development, Open-Label Studies

Balancing Cost, Quality, and Timelines in CRO Selection

June 20, 2025

digi

Balancing Cost, Quality, and Timelines in CRO Selection How to Balance Cost, Quality, and Timelines When Choosing a CRO Outsourcing clinical trial operations to a Contract Research Organization (CRO) involves a critical balance of three core factors—cost, quality, and timelines. Selecting a CRO based on one factor while overlooking the others can result in significant…

Contract Research Organizations (CROs), CRO Selection Criteria

Designing Inclusive Eligibility Criteria for Diverse Clinical Trial Enrollment

June 20, 2025

digi

Designing Inclusive Eligibility Criteria for Diverse Clinical Trial Enrollment Creating Inclusive Eligibility Criteria to Promote Diversity in Clinical Trials Eligibility criteria are foundational to the success of clinical trials. They define who can and cannot participate and directly influence the diversity, generalizability, and ethical integrity of a study. Overly narrow or restrictive inclusion and exclusion…

Diversity and Inclusion in Trials, Patient Recruitment and Retention

Designing an Effective Case Report Form (CRF): Principles and Best Practices

June 20, 2025

digi

Designing an Effective Case Report Form (CRF): Principles and Best Practices Key Principles for Designing an Effective Case Report Form (CRF) Designing an effective Case Report Form (CRF) is a critical step in ensuring the quality, accuracy, and regulatory compliance of clinical trial data. A well-structured CRF facilitates smooth data collection, aligns with study protocols,…

Case Report Form (CRF) Design, Clinical Data Management

Safeguards for Involving Children in Clinical Trials

June 20, 2025

digi

Safeguards for Involving Children in Clinical Trials Ethical Safeguards for Including Children in Clinical Trials Children are considered a vulnerable population in clinical research due to their limited capacity to provide fully informed consent and their dependency on guardians. However, pediatric trials are essential for developing safe and effective treatments tailored to this age group….

Ethical Considerations in Vulnerable Populations, Informed Consent and Ethics Committees

Building Enrollment Metrics Dashboards for Clinical Trials

June 19, 2025

digi

How to Build Enrollment Metrics Dashboards for Clinical Trial Monitoring Efficient patient recruitment is the heartbeat of successful clinical trials. Yet, many sponsors and CROs struggle with fragmented data, slow updates, and reactive decision-making. Enrollment metrics dashboards help overcome these challenges by providing real-time visibility into recruitment performance across sites, countries, and cohorts. This tutorial…

Clinical Research Operations, Patient Enrollment Strategies

Benefits and Risks of Transparency in Open-Label Studies – Clinical Trial Design and Protocol Development

June 19, 2025

digi

Benefits and Risks of Transparency in Open-Label Studies – Clinical Trial Design and Protocol Development ‘Pros and Cons of Transparency in Open-Label Research’ Introduction Open-label studies are a type of clinical research where both the researcher and the participant are aware of the treatment or intervention being administered. This form of study stands in contrast…

Clinical Trial Design and Protocol Development, Open-Label Studies

Creating Effective SDV Plan Templates and SOPs for Clinical Trials

June 19, 2025

digi

How to Create SDV Plan Templates and SOPs for Clinical Trials Standardizing Source Data Verification (SDV) is essential for ensuring consistent monitoring across sites and trials. Well-crafted SDV plan templates and SOPs guide Clinical Research Associates (CRAs) in executing and documenting SDV activities in alignment with regulatory expectations. In this tutorial, we’ll walk through the…

Site Management and Monitoring, Source Data Verification